PSS14 WHAT COST OF HLA-B5801 GENOTYPING WOULD BE COST EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND- ANALYSES USING A DECISION-ANALYTIC MODEL

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73373-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)73373-3/fulltext
Title : PSS14 WHAT COST OF HLA-B5801 GENOTYPING WOULD BE COST EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND- ANALYSES USING A DECISION-ANALYTIC MODEL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73373-3&doi=10.1016/S1098-3015(11)73373-3
First page : A564
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 1532
Categories :
Tags :
Regions :
ViH Article Tags :